Millions of people rely on pain relief drugs on a daily basis, but these treatments can carry significant side effects. Antibe Therapeutics CEO Daniel Legault details to Anthony Lacavera the startup’s new anti-inflammatory drug that provides pain relief in a novel way without the health risks associated with typical treatments.
